A key Senate panel voted along party lines Tuesday afternoon to confirm Mehmet Oz as President Donald Trump’s (R) pick [...] Read More »
Category: Federal
President Donald Trump’s (R) pick of Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS) drew new [...] Read More »
The bipartisan group of six U.S. senators behind long-awaited 340B program overhaul legislation, known as the SUSTAIN 340B Act, is [...] Read More »
A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...] Read More »
The Vermont House of Representatives voted this morning to pass a contract pharmacy access bill, the same day that a [...] Read More »
The 340B drug pricing program is drawing newfound national media attention following recent articles on a multistate dark money ad [...] Read More »
Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily [...] Read More »
Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...] Read More »
A federal judge ruled that healthcare conglomerate CVS Health did not violate antitrust laws with its contract pharmacy policies, dismissing [...] Read More »
Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...] Read More »